Health Canada — Medical Devices · Canada · 2024-09-26 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: The issue arises when a blood glucose measurement is taken and the result is displayed in the wrong measuring unit (i.e., mg/dl instead of mmol/l). If it goes unnoticed, the incorrectly displayed blood glucose value may result in inappropriate therapy decisions, including the administration of insulin, and could potentially result in severe consequences. Such possible consequences range from no clinical impact to adverse health events such as hypoglycemia. Recall start date: May 14, 2024
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.